A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects

NCT01161472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 4mg fesoterodine
DRUG: 8mg fesoterodine
DRUG: alprazolam 1mg
DRUG: Placebo

Sponsor

Pfizer